Literature DB >> 6249858

Comparison of methods available for assay of chloramphenicol in clinical specimens.

J de Louvois, A Mulhall, R Hurley.   

Abstract

Eight methods for the assay of chloramphenicol in clinical samples were compared with our own modification of a plate diffusion technique using Sarcina lutea and yeast extract agar. Six of the eight methods were less sensitive than originally reported, and five of them were considered unsuitable for use in clinical microbiology practice. The remaining three methods together with the S. lutea/yeast extract modification were used to assay chloramphenicol in 20 samples of serum. Twenty samples of cerebrospinal fluid were also assayed by the S. lutea/yeast extract method. Our results indicate that only the Bacillus subtilis (sensitivity 6x0 mg/l) and the S. lutea (sensitivity 2x5 mg/l) diffusion methods are suitable for use with clinical samples in routine practice. The problems of chloramphenicol toxicity, appropriate dosage regimens, and the need for assay of the drugs are considered.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6249858      PMCID: PMC1146146          DOI: 10.1136/jcp.33.6.575

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  An enzymatic assay for chloramphenicol with partially purified chloramphenicol acetyltransferase.

Authors:  R Daigneault; M Guitard
Journal:  J Infect Dis       Date:  1976-05       Impact factor: 5.226

2.  Simple method for elimination of aminoglycosides from serum to permit bioassay of other antimicrobial agents.

Authors:  P Stevens; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

3.  Determination of chloramphenicol in serum and cerebrospinal fluid with high-pressure liquid chromatography.

Authors:  I Nilsson-Ehle; G Kahlmeter; P Nilsson-Ehle
Journal:  J Antimicrob Chemother       Date:  1978-03       Impact factor: 5.790

4.  An enzyme preparation inactivating all penicillins and cephalosporins.

Authors:  P M Waterworth
Journal:  J Clin Pathol       Date:  1973-08       Impact factor: 3.411

5.  Determination of serum chloramphenicol utilizing gas--liquid chromatography and electron capture spectrometry.

Authors:  G L Resnick; D Corbin; D H Sandberg
Journal:  Anal Chem       Date:  1966-04       Impact factor: 6.986

6.  Mitochondrial lesions in reversible erythropoietic depression due to chloramphenicol.

Authors:  F C Firkin
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

7.  Chloramphenicol: an enzymological microassay.

Authors:  P S Lietman; T J White; W V Shaw
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

8.  The necessity for monitoring chloramphenicol levels when treating neonatal meningitis.

Authors:  S B Black; P Levine; H R Shinefield
Journal:  J Pediatr       Date:  1978-02       Impact factor: 4.406

9.  Studies on the concentrations of chloramphenicol in the serum and cerebrospinal fluid of neonates, infants, and small children. Reciprocal reactions between chloramphenicol, penicillin and phenobarbitone.

Authors:  A Windorfer; W Pringsheim
Journal:  Eur J Pediatr       Date:  1977-01-26       Impact factor: 3.183

10.  Rapid microbiological assay for chloramphenicol and tetracyclines.

Authors:  T J Louie; F P Tally; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

View more
  3 in total

Review 1.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

2.  Interaction between chloramphenicol and acetaminophen.

Authors:  J S Spika; D J Davis; S R Martin; K Beharry; J Rex; J V Aranda
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

3.  Chloramphenicol in paediatrics: current prescribing practice and the need to monitor.

Authors:  A Mulhall; D J Berry; J de Louvois
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.